Finance

Beta
Lists
603334:SHA
Suzhou Fengbei Biotech Stock Co Ltd
CNÂĄ41.66
-2.57%
(-1.10) 1D
Jun 5, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603334...
Open
CNÂĄ42.76
High
CNÂĄ43.19
Low
CNÂĄ40.90
Mkt. cap
6.14B
Avg. vol.
1.71M
Volume
1.33M
Dividend
0.84%
Quarterly dividend
CNÂĄ0.09
P/E ratio
23.50
52-wk high
CNÂĄ76.00
52-wk low
CNÂĄ40.90
EPS
CNÂĄ1.77
No. of employees
395
Open
CNÂĄ42.76
High
CNÂĄ43.19
Low
CNÂĄ40.90
Mkt. cap
6.14B
Avg. vol.
1.71M
Volume
1.33M
Dividend
0.84%
Quarterly dividend
CNÂĄ0.09
P/E ratio
23.50
52-wk high
CNÂĄ76.00
52-wk low
CNÂĄ40.90
EPS
CNÂĄ1.77
No. of employees
395
News stories
From sources across the web
About Suzhou Fengbei Biotech Stock Co Ltd
CEO-
Employees395
FoundedJul 25, 2014
Headquarters-
SectorCommodity chemical
Websitesz-fb.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
665.69M
773.28M
919.39M
1.11B
Cost of goods sold
599.24M
710.00M
866.02M
1.04B
Cost of revenue
599.24M
710.00M
866.02M
1.04B
Research and development expenses
12.14M
16.68M
17.05M
14.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.38M
14.42M
19.69M
13.50M
Operating expense
26.17M
25.41M
28.96M
17.48M
Total operating expenses
625.41M
735.41M
894.98M
1.06B
Operating income
40.29M
37.86M
24.41M
49.29M
Other non operating income
986.67K
1.17M
-1.77M
-3.63M
EBT including unusual items
39.63M
34.12M
25.80M
45.84M
EBT excluding unusual items
39.96M
35.60M
20.35M
45.86M
Income tax expense
2.95M
1.89M
2.58M
4.93M
Effective tax rate
7.45%
5.52%
9.98%
10.75%
Other operating expenses
-3.96M
-6.88M
-6.52M
-8.95M
Net income
36.67M
32.24M
23.26M
40.88M
Net profit margin
5.51%
4.17%
2.53%
3.69%
Earnings per share
-
-
-
-
Interest and investment income
137.30K
120.75K
673.13K
839.14K
Interest expense
-1.45M
-1.46M
-2.86M
-637.21K
Net interest expenses
-1.31M
-1.34M
-2.19M
201.94K
Depreciation and amortization charges
-
-
-
-
EBITDA
44.34M
41.91M
31.41M
56.29M
Gain or loss from assets sale
-
729.00
-32.84K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer